Taiwan Liposome Co Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Taiwan Liposome Co Limited with three other
companies in this sector in TAIWAN :
Pharmacore Biotech Co Ltd
sales of 163.43 million Taiwanese Dollars [US$5.58 million]
Lumosa Therapeutics Co Ltd
(172.04 million Taiwanese Dollars [US$5.88 million]
of which 100%
was Chemical & Biotech), and
Applied Biocode Corp
(104.69 million Taiwanese Dollars [US$3.58 million]
of which 92%
was Sales Revernue).
Sales increased substantially in 2019:
During the year ended December of 2019, sales at
Taiwan Liposome Co Limited were 209.14 million Taiwanese Dollars (US$7.14 million).
increase of 235.6%
versus 2018, when the company's sales were 62.32 million Taiwanese Dollars .
This was the third consecutive year of growth at Taiwan Liposome Co Limited.